TTrialPathMatch Me to Trials
← Back to trials
RecruitingCancerDiabetes

Expanding the Support of Family Caregivers of Diverse Patients With Cancer and Diabetes

Eligible age

18–99 yrs

Accepts

All genders

Locations

3 states

Healthy volunteers

Yes

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This study investigates the feasibility, acceptability, and preliminary efficacy of enCompass Humana, a social support intervention for caregivers of patients with cancer and diabetes. The enCompass program aims to improve support for these caregivers through a randomized feasibility study of a pilot-tested coaching and navigation program. Caregiver services and system-level support are essential, but successful interventions for cancer caregivers are rarely standardized or systematically disseminated. Consequently, many programs do not reach the most underserved caregivers. Challenges to implementation include substantial clinical staff involvement, lack of dissemination and implementation information, and failure to tailor interventions to rural contexts. Despite the lack of standardized supportive interventions, national reports and legislative efforts increasingly recognize the need to support caregivers. Caregivers reported unmet needs in all domains of social support, including instrumental help (e.g., in-home help, housekeeping), logistical and coordination support (e.g., food delivery, accompanying patients to appointments), information about illness and progression, emotional support, self-care guidance, and financial assistance (e.g., parking costs, lost wages). Caregivers show high interest in services but cited uncertainty and lack of strategies for accessing resources. Many are unaware of existing services. Interviews with oncology clinicians and healthcare administrators revealed similar findings: resources exist, but there is no system to match them with caregivers' needs. Preliminary data suggest the intervention improves caregiver coping self-efficacy and reduces anxiety and depression in patients. With input from stakeholders, including caregivers, patients, family caregiving experts, and clinical care experts, the study team adapted the CARING application into enCompass to mitigate structural barriers and normalize support-seeking. The long-term goal is to adapt this psychosocial support program to increase self-efficacy, support-seeking, and reduce loneliness among caregivers. It is hypothesized that enCompass will build self-efficacy and coping skills, serving caregivers throughout the patient's illness and complications.

Sponsor: UNC Lineberger Comprehensive Cancer Center

You may qualify if…

  • ✓ English-speaking.
  • ✓ Ability to provide written or verbal informed consent to participate in the study;
  • ✓ Willing and able to comply with study procedures based on the judgment of the investigator or protocol designee;
  • ✓ Be at least 18 years of age at the time of consent; and
  • ✓ Identify as an informal (unpaid) caregiver for an adult with a stage II-IV cancer AND diabetes.
  • ✓ English-speaking
  • ✓ Ability to provide informed consent.
  • ✓ Be at least 18 years of age at the time of consent; and

You may not qualify if…

  • ✕ Unable to complete self-report instruments due to illiteracy, neurologic illness, inability to speak or read English, or other causes;
  • ✕ Existence of another co-morbid disease other than diabetes, which in the opinion of the investigator, prohibits participation in the protocol;
  • ✕ Participation in the intervention development phase of this intervention
  • ✕ Self-report instruments due to illiteracy, neurologic illness, inability to speak or read English, or other causes;
  • ✕ Existence of other co-morbid disease, which in the opinion of the investigator, prohibits participation in the protocol;
  • ✕ Their caregiver does not enroll in the study or withdraws consent

Where it's recruiting

Florida

Tampa

North Carolina

Chapel Hill

Vermont

Burlington

Source: ClinicalTrials.gov · NCT07061652 · last updated 2026-08-10